The kallikrein-kinin system in experimental Chagas disease: a paradigm to investigate the impact of inflammatory edema on GPCR-mediated pathways of host cell invasion by Trypanosoma cruzi by Julio Scharfstein
“ﬁmmu-03-00396” — 2013/1/24 — 9:55 — page 1 — #1
REVIEW ARTICLE
published: 25 January 2013
doi: 10.3389/ﬁmmu.2012.00396
The kallikrein-kinin system in experimental Chagas disease:
a paradigm to investigate the impact of inﬂammatory
edema on GPCR-mediated pathways of host cell invasion
byTrypanosoma cruzi
Julio Scharfstein*, Daniele Andrade, Erik Svensjö, Ana Carolina Oliveira and Clarissa R. Nascimento
Laboratório de Imunologia Molecular, Instituto de Biofísica Carlos Chagas Filho, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro,
Rio de Janeiro, Brazil
Edited by:
Wanderley De Souza, Universidade
Federal do Rio de Janeiro, Brazil
Reviewed by:
Ravi Durvasula, University of New
Mexico School of Medicine, USA
Christy Petersen, Iowa State
University, USA
*Correspondence:
Julio Scharfstein, Laboratório de
Imunologia Molecular, Instituto de
Biofísica Carlos Chagas Filho, Centro
de Ciências da Saúde, Universidade
Federal do Rio de Janeiro, Cidade
Universitária Rio de Janeiro,
Rio de Janeiro, Brazil.
e-mail: jscharf2@gmail.com
Chronic chagasic myocarditis (CCM) depends on Trypanosoma cruzi persistence in the
myocardium. Studies of the proteolytic mechanisms governing host/parasite balance in
peripheral sites ofT. cruzi infection revealed that tissue culture trypomastigotes (TCTs) elicit
inﬂammatory edema and stimulate protective type-1 effectorT cells through the activation
of the kallikrein-kinin system. Molecular studies linked the proinﬂammatory phenotype of
Dm28c TCTs to the synergistic activities of tGPI, a lipid anchor that functions as a Toll-like
receptor 2 (TLR2) ligand, and cruzipain, a kinin-releasing cysteine protease. Analysis of
the dynamics of inﬂammation revealed that TCTs activate innate sentinel cells via TLR2,
releasing CXC chemokines, which in turn evoke neutrophil/CXCR2-dependent extravasation
of plasma proteins, including high molecular weight kininogen (HK), in parasite-laden
tissues. Further downstream, TCTs process surface bound HK, liberating lysyl-BK (LBK),
which then propagates inﬂammatory edema via signaling of endothelial G-protein-coupled
bradykinin B2 receptors (BK2R). Dm28TCTs take advantage of the transient availability of
infection-promoting peptides (e.g., bradykinin and endothelins) in inﬂamed tissues to invade
cardiovascular cells via interdependent signaling of BKRs and endothelin receptors (ETRs).
Herein we present a space-ﬁlling model whereby ceramide-enriched endocytic vesicles
generated by the sphingomyelinase pathway might incorporate BK2R and ETRs, which
then trigger Ca2+-driven responses that optimize the housekeeping mechanism of plasma
membrane repair from cell wounding. The hypothesis predicts that the NF-κB-inducible
BKR (BK1R) may integrate the multimolecular signaling platforms forged by ceramide rafts,
as the chronic myocarditis progresses. Exploited as gateways for parasite invasion, BK2R,
BK1R, ETAR, ETBR, and other G protein-coupled receptor partners may enable persistent
myocardial parasitism in the edematous tissues at expense of adverse cardiac remodeling.
Keywords: bradykinin, cardiomyopathy, cruzipain, endothelins, GPCRs, proteases, kallikrein,Trypanosoma cruzi
INTRODUCTION
Afﬂicting nearly 10 million people in Latin America (Coura and
Dias, 2009), Chagas disease is a pleiomorphic clinical entity caused
by Trypanosoma cruzi, a parasitic protozoan that undergoes obli-
gate intracellular development in the mammalian host. Extremely
polymorphic (Macedo and Pena, 1998), the natural populations
of T. cruzi have been recently subdivided into six discrete taxo-
nomic units (DTUs) named T. cruzi I to T. cruzi VI (Zingales et al.,
2009), of which at least four are known to be involved with human
pathology (Miles et al., 2009). Whether transmitted to humans via
mucosal wounds inﬂicted by hematophagous vectors of the redu-
viid family or, indirectly, by oral ingestion of contaminated juices
(Coura and Dias, 2009; Cortez et al., 2012), the insect-derived
infective forms (metacyclic trypomastigotes) induce an acute
phase that may be asymptomatic, or life-threatening. Character-
ized by high blood parasitemia, the sequels of severe acute disease
may include hepatosplenic pathology, myocarditis, and more
rarely, encephalitis. Lasting a few months, the acute symptoms
subside with the onset of immunity, but the effector response
is not capable of eradicating the intracellular parasites, leading
to a chronic infection, characterized by low-grade tissue para-
sitism and positive serology. Several years later, about 30% of
the patients develop a full-blown chronic chagasic myocardiopa-
thy (CCM), characterized by the presence of inﬂammatory T
cell inﬁltrates, myocardial ﬁbrosis, complex arrhythmias, throm-
boembolism, andventricular aneurysms (Marin-Neto et al., 2007).
Patients with severe forms of CCM may have heart failure and
sudden death, while the remaining chagasic patients (indetermi-
nate stage) remain asymptomatic for decades. In the south cone
of America, chagasic patients may also develop digestive system
abnormalities (megacolon and/ormegaesophagus), albeit in lower
frequency than CCM.
CCM: CONVERGING PATHOGENIC MECHANISMS
Nearly a century after the discovery of Chagas disease, we have
come to realize that the mechanisms responsible for the variable
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clinical manifestations during the chronic phase are still elusive.
Cardiac parasympathetic depopulation, microvascular derange-
ment, and low-grade myocardial inﬂammation directly induced
by parasites and T cell-dependent immunopathology seem to
converge in the genesis of CCM. After decades of debate, there
are persuasive arguments supporting the notion that the pri-
mary cause of CCM is a low-grade, persistent parasitism of the
myocardium (Tarleton, 2001). A large body of studies in mice and
humans indicated that chronic myocarditis is critically dependent
on the recruitment of parasite-speciﬁc (type 1) effector CD8 T
cells to the infected cardiac tissues (Padilla et al., 2009; Silverio
et al., 2012).
While not dismissing the relevance of intracardiac inﬁltrates in
the progression of CCM, vascular pathologists argued that low-
grade infection could lead to the accumulation of microvascular
lesions in the chagasic heart, ultimately resulting in myocar-
dial hypoxia, which in turn may aggravate collateral injury
inﬂicted by pathogenic T cells inﬁltrating the heart (Morris
et al., 1990; Rossi, 1990; Higuchi et al., 1999, 2003). Subse-
quent studies in experimentally infected animals shed light on
the mechanisms by which T. cruzi induces microvasculopathy
(Andrade et al., 1994; Tanowitz et al., 1999). Initial observa-
tions ascribed the formation of vasospasm to the pathogenic
activity of endothelins (ETs), a potent class of vasoconstrictor
polypeptides (Tanowitz et al., 1999). Of further interest, these
workers reported that endothelin-1 (ET-1) expression is up-
regulated in parasitized cardiovascular cells (Petkova et al., 2000).
Follow-up studies in chronically infected mice demonstrated that
cardiac remodeling signiﬁcantly ameliorated in transgenic lines
in which the ET gene was speciﬁcally removed from cardiomy-
ocytes, while ablation of this gene in endothelial cells has not
signiﬁcantly reduced heart ﬁbrosis (Tanowitz et al., 2005). Of
further interest, the plasma levels of ETs are elevated both in
chagasic patients and infectedmice (Petkova et al., 2000; Salomone
et al., 2001).
While the research linking infection-associated vasculopathy
to the function of ETs progressed, our group reported that try-
pomastigotes generate proinﬂammatory kinin peptides extravas-
cularly. Follow-up studies indicated that the local activation of
the kallikrein-kinin system (KKS) translates into mutual bene-
ﬁts to the host/parasite relationship during the course of chagasic
infection (Scharfstein and Andrade, 2011; Scharfstein and Sven-
sjö, 2012). In the present article, we will review the results of
these studies and advance the proposition that T. cruzi may take
advantage of interstitial edema in the inﬂamed heart to potentiate
their infectivity via cooperative signaling of multiple G protein-
coupled receptors (GPCRs). The rationale of this hypothesis lies
on two fundamental premises: (i) due to the low-grade parasitism
observed in chronic infection, there are intermittent "ﬂares" of
plasma leakage in the inﬂamed myocardium (ii) the microvas-
cular edema is temporally linked to the release of parasites from
ruptured pseudocysts (Scharfstein and Morrot, 1999).
Studies in various experimental models indicated that tis-
sue culture-derived trypomastigotes (Dm28c) swiftly activate
microvascular beds through the activation of the KKS (Todorov
et al., 2003; Monteiro et al., 2006; Schmitz et al., 2009; Scharf-
stein and Andrade, 2011; Andrade et al., 2012). Based on these
initial observations, we predicted that the sudden diffusion of
plasma-borne constituents (antibodies, complement components,
kininogens, ETs) through parasite-laden tissues may affect the del-
icate host/parasite balance established in the chronically infected
myocardium. Although the ﬂagellated trypomastigotes released
from pseudocysts may rapidly move away from the primary foci
of infection, hence seeking for safer targets elsewhere in the
myocardium, we proposed that the transient rise of plasma pro-
teins in the edematous interstitial spaces might favor generation
of infection-promoting peptides, such as bradykinin (BK), in the
peripheral tissues (Scharfstein et al., 2000; Todorov et al., 2003;
Andrade et al., 2012). Before outlining the arguments support-
ing this working hypothesis, we will present readers with an
overview of the essential structural and functional features of
the KKS.
MOLECULAR BASIS OF KKS ACTIVATION AND REGULATION
Recently implicated in thrombo-inﬂammatory processes (Müller
et al., 2009; von Brühl et al., 2012), the KKS is a hub-like network
of proteolytic enzymes which, among other biological functions,
release the proinﬂammatory “kinin” peptides from an internal
segment of their plasma-borne precursors, the kininogens. Gen-
eration of kinins may involve multiple processing enzymes: in
the bloodstream, plasma kallikrein (PK) releases the nonapeptide
BK from high molecular weight kininogen (HK) upon activa-
tion of the contact system by negatively charged surfaces, such
as platelet-derived polyphosphates (Figure 1A). In the extravas-
cular spaces, lysyl-BK (LBK) is excised from low molecular weight
kininogen (LK) or HK by tissue kallikrein, a serine protease that is
constitutively expressed in multiple tissues. It is also known that
kinins can be generated by alternative proteases. For example, in
chronic inﬂammation kininogens may be processed by the con-
certed action of neutrophil elastase and mast cell tryptase, leading
to the release of a slightly larger kinin,Met-LBK(Kozik et al., 1998).
In the context of infections, kinins can be directly liberated from
the kininogens by the action of microbial cysteine proteases, such
as gingipain fromPorphyromonas gingivalis (Imamura et al., 1994),
staphopain A from Staphylococcus aureus (Imamura et al., 2005),
streptopain from Streptococcus pyogenes (Herwald et al., 1996), and
cruzipain (Del Nery et al., 1997; Scharfstein et al., 2000; Monteiro
et al., 2006).
The biological responsesmediated byBK andLBKaremediated
by bradykinin B2 receptor (BK2R), a subtype of heterotrimeric
G-protein-coupled BKR (Figure 1A) which is constitutively
expressed by several cell types, including cardiomyocytes, pain-
sensitive neurons, vascular endothelial cells, smooth muscle cells
(Leeb-Lundberg et al., 2005). As explained later on in this text,
kinins (BK/LBK) also activate BK2R expressed by sentinel cells
of the innate immune system, such as conventional dendri-
tic cells (DCs; Aliberti et al., 2003; Bertram et al., 2007; Kaman
et al., 2009).
Once released from HK/LK, the intact kinins (BK/LBK) have a
half-life of <15 s in the plasma, hence must swiftly activate BK2R
via the paracrine mode (Figure 1A). Since excessive activation of
the kinin system may have adverse effects to the vascular system,
the kinin/BK2Rpathway is ﬁned-tunnedbyoverlapping regulatory
mechanisms, such as (i) down-regulation of surface BK2R
Frontiers in Immunology | Microbial Immunology January 2013 | Volume 3 | Article 396 | 2
“ﬁmmu-03-00396” — 2013/1/24 — 9:55 — page 3 — #3
Scharfstein et al. Parasite invasion potentiated by bradykinin/endothelins
FIGURE 1 | (A) Activation of the kallikrein-kinin systemTop: The scheme
depicts platelet-derived polyphosphates (PolyP) acting (intravascularly) as
endogenous activators of the KKS (contact phase of coagulation). The
proteolytic cascade is initiated as the negatively charged PolyP (long chains)
bind to (i) FXII and (ii) HK, via the histidine-rich (D5) domain. PolyP-induced
conformational changes in FXII lead to its autocatalytic cleavage. FXIIa then
cleaves the plasma kallikrein (PK) zymogen, generating PKa. After several
cycles of reciprocal activation between PKa/FXIIa, FXIIa activates FXI, the
downstream effector of the intrinsic coagulation pathway, whereas PKa
cleaves HK, releasing the internal nonapeptide bradykinin (BK, green
rectangle). In inﬂammatory conditions, the plasma-borne HK/LK diffuse
through post-capillary venules. As the extravascular levels of kininogens
rise, these kinin-precursor molecules undergo cleavage by tissue kallikrein
(TK), which liberates the decapeptide lysyl-BK. Acting by the paracrine
mode, the intact form of kinins (BK or Lysyl-BK) binds at high-afﬁnity to
BK2R, a subtype of BKR that is constitutively expressed in a broad range of
cell types. Bottom: The scheme depicts the activation requirements of
BK1R, a GPCR subtype whose expression is strongly upregulated in
inﬂamed/damaged tissues. Generation of high-afﬁnity ligands for the
inducible BK1R depends on metabolic processing of the intact kinins (BK or
lysyl-BK) by the metallopeptidase kininase I (carboxypeptidase N or
membrane-bound carboxypeptidase M). (B) BK1R is an inducible gateway
forT. cruzi entry in cardiovascular cells.T. cruzi relies on the enzymatic
versatility of the major lysosomal cysteine protease (cruzipain) to release
LBK from HK molecules docked to the host cell surfaces via binding to
heparan sulfate proteoglycans. Once released, the short-lived lysyl-BK is
rapidly processed by membrane-bound carboxypeptidase M, generating
[des-Arg]-lysyl-BK, which then enhances parasite infectivity through the
signaling of the inducible BK1R.
(ii) degradation of intact kinins by various metallopeptidases,
including angiotensin converting enzyme (ACE, kininase II) – a
transmembrane di-peptidyl carboxypeptidase (Skidgel and Erdos,
2004) highly expressed in the endothelium lining and, to a less
extent, in other cell types, including innate sentinel cells such
as monocytes and DCs (Danilov et al., 2003). Besides degrading
intact kinins, thus reducing hypotension, ACE increases blood
pressure through the formation of angiotensin II, a potent vaso-
pressor octapeptide. Noteworthy, the transmembrane (somatic)
enzyme undergoes cleavage by disintegrin and metalloproteinase
(ADAM)-type“sheddase”(Parkin et al., 2004), leading to the accu-
mulation of soluble forms of ACE in the blood and other body
ﬂuids.
In contrast to the constitutive BK2R, the expression of BK1R
is strongly – but transiently – up-regulated during inﬂamma-
tion (Marceau and Bachvarov, 1998; Figure 1A). For example,
ET-1 and angiotensin II induce BK1R expression through the sig-
naling of ETAR and AT1 (angiotensin 1 receptor) respectively,
leading to activation of phosphoinositide 3-kinase (PI3K) and
mitogen-activated protein kinases (MAPK) cascade (Medeiros
et al., 2004). BK1R is also induced by IL-1β, TNF-α, and IFN-
γ via the NF-κB transcription factor (Marceau and Bachvarov,
1998; Medeiros et al., 2004; Moreau et al., 2007). Differently from
BK2R, the inducible BK1R is not triggered by “intact” kinins
(BK/LBK). Instead, BK1R is activated by the kinin metabolites
[des-Arg]-BK or [des-Arg]-LBK, both of which are generated by
carboxypeptidase N (CPN)/carboxypeptidase M (CPM) (kini-
nase I)-mediated cleavage of the C-terminal arginine residue of
BK/LBK (Figure 1A).
BIOLOGICAL FUNCTIONS OF BKRs
In the cardiovascular system, kinins/BK2R control the blood ﬂow
through nitric oxide (NO)-dependent vasodilation. In contrast
to the beneﬁcial role of kinins in cardiovascular homeostasis,
there is evidence that dysregulated BK1R signaling drives myocar-
dial ﬁbrosis and impairs heart function in different experimental
models (Spillmann and Tschöpe, 2012).
Beyond inducing detrimental cardiac responses, it is well-
established that BK1R plays a major role in hyperalgesia (Calixto
et al., 2004; Gabra et al., 2005; Cunha et al., 2007). Studies in
mice subjected to traumatic brain injury revealed that blood-
brain leakage and recruitment of inﬂammatory leukocytes to
the CNS is blocked by a speciﬁc BK1R antagonist (Raslan
et al., 2010). Although inﬂammation is usually initiated through
the signaling of the constitutive BK2R, the sustenance of the
inﬂammatory response depends on the signaling of endothe-
lial BK1R. McLean et al. (2000) were the ﬁrst to report that the
trans-endothelial leukocyte migration is enhanced as result of
up-regulated expression/signaling of endothelial BK1R. Recent
progress in studies of experimental autoimmune encephalitis
(EAE) demonstrated that BK1R increases the recruitment of
pathogenic effector T cells into the CNS (Dutra et al., 2011; Göbel
et al., 2011; Table 1).
More recently, a growing number of studies indicated that
immune resistance against infection by parasitic protozoan (Mon-
teiro et al., 2006, 2007; Svensjö et al., 2006; Nico et al., 2012;
Scharfstein and Svensjö, 2012) and bacterial pathogens (Kaman
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Table 1 | Role of BKRs in immunity: literature update.
Experimental System Bradykinin
receptor
subtype
Functional Roles of BKRs Reference
T. cruzi infection (mice) BK2R Induction of CD11c+ DC (splenic) maturation and upregulation of
effector (type 1) CD4 and CD8 T cells
Monteiro et al. (2006);
Monteiro et al. (2007)
L. donovani and L. chagasi (hamsters
and mice)
BK2R Inﬂammatory edema induced by promastigotes; stimulation of
promastigote uptake and modulation of the intracellular growth
of leishmania in macrophages
Svensjö et al. (2006)
Visceral Leishmaniasis (mice) BK2R Immune resistance to acute infection Nico et al. (2012)
L. monocytogenes infection (mice) BK2R Modulation of innate immunity and infection control Kaman et al. (2009)
P. gingivalis infection-bucal (mice) BK2R Upregulation of Th1 andTh17 responses (submandibular
lymph node)
Monteiro et al. (2009)
In vivo leukocyte trafﬁcking across
mesenteric postcapillary venules (mice)
BK1R Trans-endothelial leukocyte migration McLean et al. (2000)
EAE (mice) BK1R Th1 andTh17 responses development and clinical
progression of EAE
Dutra et al. (2011)
Induction of blood brain barrier disruption andT cell
transmigration into the CNS
Göbel et al. (2011)
Limiting inﬁltration of pathogenic subsets of effector CD4
T cells into the CNS
Schulze-Topphoff et al. (2009)
In vitro DC migration (human) BK2R Stimulation of DC migration Bertram et al. (2007)
BK1R Inhibition of DC migration Gulliver et al. (2011)
Allergic inﬂammation (mice) BK1R/BK2R Induction/inhibition of migration and activation of eosinophils Vasquez-Pinto et al. (2010)
BK2R Induction of DC maturation and IL-12-dependent Th1 polarization Aliberti et al. (2003)
et al., 2009) is critically dependent on activation of innate sentinel
cells via the BK2R pathway (Table 1).
BKRs: DOMAIN COMPARTMENTALIZATION, REGULATION,
AND SIGNAL TRANSDUCTION PATHWAYS
Stably expressed at the cell surface, the constitutively expressed
BK2R is rapidly desensitized/internalized via GRK4α-mediated
receptor phosphorylation upon ligand binding, thus yielding a
transient signaling response (Blaukat et al., 2001). Using BK2R-
fusion constructs, Enquist et al. (2007) revealed that upon BK
binding, the internalized receptors colocalize with transfer-
ring in endosomes, prior to entry in the arrestin-dependent,
clathrin-mediated recycling pathway. A second trafﬁcking path-
way, described in smooth muscle cells and ﬁbroblasts, indicated
that BK also promotes the redistribution of BK2R and their
coupling G proteins to caveolar rafts (de Weerd and Leeb-
Lundberg, 1997).
Although the cellular systems vary from one report to
another, it is well-established that BK binding to BK2R pro-
motes the formation of BK2R homodimers and oligomer
complexes of higher order (Leeb-Lundberg et al., 2005). Kang
et al. (2004) reported that BK2R and BK1R form heterodimers
in transfected HEK293 cells. Notably, BK2R also forms het-
erodimeric complexes with-type-1 angiotensin receptors (AT1) in
vascular smooth muscle cells and transfected HEK293 (AbdAlla
et al., 2001).
As to the signal transduction pathways, it is well established
that BK frequently induces BK2R-dependent [Ca2+]i transients
and PLC-β-dependent hydrolysis of phosphoinositides, both of
which commonly coupled to the activation of PKC isoenzymes α,
ε, and ξ. Although BK2R often signals through Gαq and Gαi, in
some cellular systems BK-driven activation of the constitutively
expressed BKR is coupled to Gαs and Gα12/13 (Leeb-Lundberg
et al., 2005). Similar to the effects induced by other GPCR ago-
nists, BK sequesters BK2R along with Gαq and Gαi in caveolar
compartments of smooth muscle cells (de Weerd and Leeb-
Lundberg, 1997).
In ﬁbroblasts, a cell-type often used in models studies of
T. cruzi interaction with non-professional phagocytic cells, BK2R
activation is associated with transient tyrosine phosphorylation
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and activation of focal adhesion kinase as well as other focal-
adhesion substrates (Leeb-Lundberg et al., 1994). In another
study with ﬁbroblasts, BK stimulated peripheral actin microspikes
and membrane rufﬂing via activation of Cdc42 and Rac-1
(Kozma et al., 1995). Studies with endothelial cells showed
that BK, acting as a potent vasodilator, transiently stimulates
endothelial cell production of NO via endothelial nitric oxide
synthase (eNOS) through mechanisms involving both calcium-
dependent and phosphorylation cascades mediated by PI3K/Akt
(Kuhr et al., 2010).
KKS HAS A DUAL ROLE IN EXPERIMENTAL
CARDIOMYOPATHIES
All the components of the KKS are present in the heart. In addition
to contributing to vascular tone and inﬂammation in the cardiac
tissues, the KKS inﬂuences extent of extracellular matrix (ECM)
remodeling, angiogenesis, and stem cell mobilization (Spillmann
et al., 2006). Of possible relevance to the understanding of KKS
function in CCM, experimental studies in mouse models of
diabetic cardiomyopathy and myocardial ischemia indicate that
speciﬁc alterations in kinin homeostasis may either ameliorate or
worsen cardiac pathology after cardiac pathology (Spillmann and
Tschöpe, 2012).
As mentioned earlier, the beneﬁcial effects of ACE inhibitors
are due to their dual biological functions: these potent drugs
block ACE-driven conversion of angiotensin I into the vasopres-
sor angiotensin II and inhibit the enzymatic breakdown of kinins
(BK2R agonists), thus increasing the half-life of “intact” kinins
in the circulation. Noteworthy, ACE inhibitors reduce myocar-
dial damage (e.g., reduction of infarction size) yet these effects
were nulliﬁed upon treatment with BK2R antagonists or in BK2R-
deﬁcient mice (Yang et al., 2001), thus indicating that signaling of
BK2R has a major function in the remarkable protective effects of
ACE inhibitors.
Studies in streptozotocin (STZ)-induced models of diabetic
cardiomyopathy have shown that early left ventricle (LV) and
systolic dysfunction is improved in mice overexpressing tis-
sue kallikrein (KLK1), whereas wild-type heart develop mas-
sive ﬁbrosis (interstitial and perivascular) due to focal accu-
mulation of collagen and ﬁbrillar fragmentation. Although
KLK1 has a pro-collagenase activity by itself and may activate
matrix metalloproteinases (MMPs), the host-protective effects
of KLK1 overexpression in diabetic cardiomyopathy were abol-
ished upon treatment with HOE-140 (BK2R antagonist), thus
implying that KLK1-mediated release of kinins improves car-
diac function. Additional studies suggested that activation of
the KLK1/BK2R pathway reduces cardiac ﬁbrosis through the
activation of the plasminogen activator/MMP2-dependent ﬁb-
rinolytic cascade (Spillmann et al., 2006). Additional studies
revealed that BK2R signaling that BK2R signaling improves
cardiac function by (i) reducing apoptosis and chamber dilata-
tion in the myocardium (Chao et al., 2008), (ii) optimiz-
ing angiotensin II-induced (NO-dependent) neovascularization
(Munk et al., 2007), (iii) restoring S2a-mediated sarcoplasmatic
Ca2+ uptake (Tschöpe et al., 2005), and/or (iv) promoting hom-
ing of endothelial progenitor cells to ischemic muscles (Kränkel
et al., 2008).
T. cruzi TRYPOMASTIGOTES LIBERATE KININS
FROM SURFACE-BOUND KININOGENS VIA
CRUZIPAIN
The ﬁrst clues suggesting that T. cruzi is equipped with a kinino-
genase came from enzymatic analysis of the substrate speciﬁcity
of cruzipain (Del Nery et al., 1997), a lysosomal-like cysteine
protease classiﬁed as member of clan A of the C1 peptidase fam-
ily (Cazzulo et al., 2001; Alvarez et al., 2012). At ﬁrst sight, the
discovery that cruzipain acted as a “kininogenase” seemed para-
doxical because kininogens are members of the cystatin family of
cysteine protease inhibitors, hence rely on cystatin-like domains
to potently inactivate papain-like enzymes, including cruzipain
itself (Stoka et al., 1995). Consistent with this, in vitro data
showed that cruzipain hydrolyzes soluble forms of HK at slower
rates as compared to tissue kallikrein. This conundrum was set-
tled by awareness that HK binds to negatively charged sulfated
proteoglycans, such as heparan or chondroitin sulfates via the
histidine-rich positively charged motif (D5H) localized at the C-
terminal end of the BK (D4) sequence (Renné et al., 2000; Renné
and Muller-Esterl, 2001). Based on this information, Lima et al.
(2002) hypothesized that the spatial orientation of cell-bound
HK docked to heparan sulfate proteoglycans was not suitable for
cruzipain binding and inactivation by the cystatin-like inhibitory
domain (Figure 1B). Indeed,model studies performed with cruzi-
pain and HK in the test tube offered circumstantial support to
this hypothesis (Lima et al., 2002): the addition of heparan sul-
fate (at optimal concentrations) drastically reduced the cysteine
inhibitory activity of soluble HK on cruzipain while reciprocally
increasing the catalytic efﬁciency of the parasite protease, mea-
sured with synthetic peptides ﬂanking the BK sites. Consistent
with these results, heparan sulfate potentiated HK processing by
cruzipain, generating multiple HK breakdown products and pro-
moting accelerated kinin release (Figure 1B). Combined, these
biochemical studies suggested that the substrate speciﬁcity of the
parasite protease was re-directed as result of reciprocal interac-
tions between sulfated proteoglycans with the substrate (HK) and
protease (cruzipain) molecules (Lima et al., 2002), hence increas-
ing the efﬁciency of the kinin-release reaction in peripheral sites
of infection.
Previously characterized as a therapeutic target of Chagas
disease (McKerrow et al., 2009), cruzipain is a remarkably ver-
satile virulence factor of T. cruzi. Beyond activation of the KKS
(see below), the proteolytic activity of cruzipain was impli-
cated in mechanisms of parasite virulence/pathogenicity, such as
lence/pathogenicity, such as (i) enhancement of trypomastigote
invasion and intracellular replication of amastigotes in cardiomy-
ocytes (Meirelles et al., 1992; Scharfstein et al., 2000), (ii) degrada-
tion of proinﬂammatory chemokines (Benítez-Hernández et al.,
2010), and (iii) subversion of innate microbicidal responses in
parasitized macrophages through interference with the activation
of NF-κB (Doyle et al., 2011).
KININ RELEASE IN PERIPHERAL SITES OF T. cruzi INFECTION
DEPENDS ON THE COOPERATIVE ROLES OF tGPI AND
CRUZIPAIN
Vertebrate hosts may control infection by rapidly mobilizing solu-
ble and cellular-based microbicidal systems that destroy pathogen
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invaders at the cost of limited self-tissue destruction. Perturba-
tions of steady-stated tissue homeostasis are sensed by sentinel
cells of the innate immune system through specialized pattern-
recognition receptors (PRRs; Medzhitov and Janeway, 1997). In
many infections, the activation of PRRs lead to rapid secretion
of pre-formed vasoactive mediators by innate sentinel cells (e.g.,
eicosanoids, leukotrienes, chemokines, TNF-α), which then
activate the endothelium lining, rendering them sticky for cir-
culating neutrophils. Further downstream, vasoactive mediators
generated/released at the neutrophil/endothelial interface impair
the integrity of the endothelial barrier, hence opening the “ﬂood
gates” (DiStasi and Ley, 2009).
Studies in a mouse model of subcutaneous (footpad) infec-
tion provided the ﬁrst evidence that Dm28c TCTs (tissue culture
trypomastigotes) induce inﬂammatory edema through the acti-
vation of the kinin system (Todorov et al., 2003; Figure 2A). A
footpad edema potentiated by the ACE inhibitor captopril was
observed 2 h p.i. in wild-type B6 mice, but not in BK2R-deﬁcient
mutants. Using pharmacological tools, we showed that the consti-
tutively expressed BK2R orchestrated the early phase (2 h) edema,
whereas BK1R (acting in “cross-talk” with BK2R) sustained the
inﬂammatory response (24 h; Todorov et al., 2003). Intriguingly,
Dm28c epimastigotes failed to induce a conspicuous inﬂammatory
edema via the kinin pathway despite the fact that these vector-
borne non-infective forms express abundant levels of cruzipain.
In a subsequent study, it became clear, for reasons that will be
explained further below, that cruzipain was necessary but not suf-
ﬁcient to generate kinins in hamster cheek pouch (HCP) topically
exposed to Dm28c epimastigotes.
Insight of the functional interplay between Toll-like recep-
tor (TLR)-driven innate responses and the KKS emerged from
analysis of the mechanisms underlying TCT-evoked microvascu-
lar leakage responses induced by topically applying the pathogen
to the HCP (Monteiro et al., 2006). This unconventional sys-
tem proved advantageous because it dispensed the use of nee-
dle to inject parasites, hence avoiding activation of the KKS
by bleeding and traumatic injury. Using intravital microscopy,
we found that Dm28c TCTs induced discrete plasma leakage
responses in the HCP within a few minutes of parasite applica-
tion. Noteworthy, the microvascular reactions were attenuated
by HOE-140 (BK2R antagonist) or by pretreating the TCTs
with an irreversible cruzipain inhibitor N-methyl-piperazine-
Phe-homoPhe-vinyl sulfone (K11777), an anti-parasite drug that
will be soon tested in clinical trials (Engel et al., 1998; McKerrow
et al., 2009).
Monteiro et al. (2006) highlighted the fact that puriﬁed cruzi-
pain (activated) topically applied to the HCP failed to induce
signiﬁcant plasma leakage even in the presence of ACE inhibitors.
However, puriﬁed (activated) cruzipain induced a strong BK2R-
driven leakage response when it was applied in combination to
puriﬁed HK. The dependence on a supply of exogenous HK sug-
gested that, in resting state conditions (i.e., in the absence of
inﬂammation), the levels of endogenous kinin-precursor proteins
in the interstitial spaces are insufﬁcient to allow for signiﬁcant acti-
vation of the kinin system. Based on these observations, Monteiro
et al. (2006) predicted that Dm28c TCTs might bear develop-
mentally regulated proinﬂammatory molecules (i.e., absent in
Dm28c epimastigotes) which control the rate-limiting step of
KKS activation in parasite-laden tissues: the inﬂux of the plasma-
borne kininogen (cruzipain substrate) into peripheral sites of
T. cruzi infection (Figure 2A). Seeking to identify these fac-
tors, Monteiro et al. (2006) then turned their attention to tGPI,
a mucin-linked lipid anchor previously characterized by Almeida
and Gazzinelli (2001) as a TLR2 ligand that was expressed at high-
levels exclusively in TCTs. Consistent with the working hypothesis,
Dm28TCTs failed to evoke inﬂammatory edema inTLR2−/− mice
or in BK2R−/− mice (Monteiro et al., 2006). In contrast, these
infective parasites evoked a prominent edema both in wild-type
mice and TLR4 mutant (C3H/HeJ). These results argued against a
role forGIPL, a lipid anchor of epimastigotes previously character-
ized asTLR4 ligand (Oliveira et al., 2004), in the activationpathway
that generates vasoactive kinins in peripheral sites of infection.
Next, Monteiro et al. (2006) studied the functional interplay
between TLR2 and the KKS by injecting TLR2-deﬁcient mice
with a parasite suspension supplemented (or not) with puriﬁed
HK. Strikingly, the injection of HK in infected TLR2−/− mice
rescued the edema response. Moreover, the edema responses
which HK induced in TLR2−/− infected mice were abolished
by HOE-140, or alternatively, by pre-incubating the TCTs
with the irreversible cruzipain inhibitor K11777. Combined,
these results supported the hypothesis that TCTs induce the
initial leakage/accumulation of the HK (cruzipain substrate)
in peripheral tissues via TLR2, whereas cruzipain ampliﬁes
this inﬂammatory response through the release of BK2R ago-
nist, at the downstream end of the inﬂammatory cascade
(Figure 2A).
In order to further conﬁrm this hypothesis, Monteiro et al.
(2006) injected (s.c.) puriﬁed tGPI, combined or not to activated
cruzipain, in wild-type naïve mice or in TLR2−/− or BK2R−/−
mutants. Edema measurements showed that tGPI/cruzipain
potently induced microvascular responses via the TLR2/BK2R-
pathway and these proinﬂammatory effects were further potenti-
ated by ACE inhibitors. Beyond their effects on the microcircula-
tion, the released kinins link TLR2-driven inﬂammation to innate
immunity by triggering BK2R expressed on resident/migrating
DCs, converting them into TH1-directing antigen-presenting cells
(APCs;Monteiro et al., 2006). Conversely,ACEcounter-modulates
TH1-polarization via the trans-cellular the TLR2/BK2R pathway
by degrading BK/LBK, an endogenous signal that drives DCmatu-
ration (Aliberti et al., 2003; Monteiro et al., 2006, 2007; Scharfstein
et al., 2007).
NEUTROPHIL LINKS TLR2/CXCR2 TO THE PROTEOLYTIC (KKS)
PHASE OF INFLAMMATION
A key event at early stage of infection, the interaction of circulat-
ing neutrophils with the endothelium has profound effects on the
outcome of the inﬂammatory process. One of the most common
consequences of the interactions that take place on the luminal side
of post-capillary vessels is the increased vascular permeability, a
biological response that leads to the accumulation of protein-rich
edema ﬂuid in interstitial spaces. Although the list of endogenous
soluble factors that increase vascular permeability is extensive, they
usually impair the integrity of the endothelial barrier through
the triggering of [Ca2+]I – the via signaling of heterotrimeric
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FIGURE 2 | Influence of interstitial edema on host/parasite balance in
the myocardium: lessons from studies with the Dm28c strain ofT. cruzi .
(A) (1) Despite the scanty parasitism in the myocardium of chronic chagasic
patients, parasite-containing pseudocysts occasionally burst, releasing high
numbers of pro-inﬂammatory trypomastigotes into the surrounding interstitial
spaces. (2) Innate sentinel cells, such as macrophages and/or mast cells,
(Continued)
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FIGURE 2 | Continued
initiate inﬂammation through the sensing of tGPI, a TLR2 ligands shed by
trypomastigotes. (3) In response to TLR2 engagement, tissue macrophages
release CXC chemokines, which in turn activate neutrophils/endothelium
via CXCR2. (4) Vascular permeability is increased, leading to the
diffusion/accumulation of plasma proteins (including kininogens) through
parasite-laden interstitial spaces. Once bound to heparan sulfate
proteoglycans, HK suffers proteolytic attack by cruzipain (CZP) secreted by
trypomastigotes. (5) The released kinins (LBK) amplify plasma leakage
through the activation of endothelium BK2R. The levels of intact kinins
keep rising, despite the counter-regulatory role of ACE. (B) (6) Whether
originating from plasma (following diffusion to sites of infection) or secreted
by parasitized cardiomyocytes, ET-1 activates perivascular mast cells via
ETAR. Upon degranulation, the mast cell release histamine (which further
increases plasma leakage) and heparin, in the peripheral tissues. (7) The
plasma “contact” phase system may be activated by mast cell-derived
heparin and/or other negatively charged molecules of endogenous origin,
such as DNA present in extracellular traps. Once activated by FXIIa, PKa
releases BK from HK, thus propagating the proteolytic cascade. (8) Intact
kinins are metabolized by kininase I (CPM and/or CPN), generating
[des-Arg]-BK, which in turn activate BK1R (whose expression is up-regulated
in a broad range of heart cells, including cardiomyocytes-shown at the
center of the illustration). (9) The parasites take advantage of the local
availability of infection-promoting peptides (ET1, BK and/or [des-Arg]-kinins)
to persistently invade cardiovascular cells through the signaling
(“cross-talk”) between BK2R/BK1R/ETAR/ETBR. (10) Intracellular parasite
outgrowth leads to increased expression of pro-oxidative/pro-ﬁbrotic ET-1
and proinﬂammatory chemokines. (11) Adverse cardiac remodeling ensues,
as result of vicious cycles of ET-1-driven triggering of cardiac mast cells,
endothelial activation and BK1R-driven recruitment of pathogenic subsets of
effector CD8+ T cells into the heart.
G-proteins, i.e., a pathway required to induce myosin-dependent
contraction and junctional disruption of the endothelial
cells.
In the HCP studies described in the previous section, Mon-
teiro et al. (2006) observed that circulating leukocytes rapidly
adhered to the luminal face of post-capillary venules. Com-
plementary studies performed in neutrophil-depleted wild-type
mice revealed that Dm28 TCTs failed to evoke a conspicu-
ous edema in these animals. Similar to the pharmacological
maneuvers employed with TLR2−/− mice, already described,
the deﬁcient phenotype of neutrophil-depleted mice was res-
cued upon injection of TCT supplemented with HK (Monteiro
et al., 2006). Collectively, these results supported the concept
that neutrophils, acting at the early stages of the inﬂammatory
response, link innate immunity (TLR2-driven) to the KKS by driv-
ing the diffusion/accumulation of plasma-borne kininogens into
parasite-laden tissues (Figure 2A).
In a subsequent study, Schmitz et al. (2009) investigated
whether macrophages could also play a role in the trans-cellular
“cross-talk” mediated by TLR2/BK2R. First, they asked whether
macrophages incubated with TCTs or tGPI in vitro stimulated the
secretion of CXC chemokines (KC/MIP-2). The results revealed
that wild-type macrophages robustly responded to Dm28c TCTs
(but not to epimastigotes), whereas TLR2−/− macrophages were
unresponsive to both stimuli. Turning to the HCP model, intrav-
ital microscopy studies showed that the drug repertaxin (CXCR2
antagonist) blocked leukocyte accumulation in the microvascu-
lar beds of HCP topically exposed to TCTs and inhibited the paw
edema in T. cruzi-infected mice (Schmitz et al., 2009). Collectively,
these ﬁndings supported the concept that Dm28c TCTs evoke
inﬂammatory edema via the TLR2/CXCR2/BK2R axis, a sequen-
tial pathway of activation forged by the trans-cellular “cross-talk”
of tissue resident macrophages, neutrophils and the endothelium
(Figure 2A).
FURTHER EXPANSION OF THE INFLAMMATORY WAVE: THE
CONVERGENCE BETWEEN ENDOTHELIN AND KININ
PATHWAYS
Encoded by distinct genes, ET-1, 2, and 3 are closely related pep-
tides expressed by endothelial cells, cardiac myocytes, and cardiac
ﬁbroblasts (Goto, 2001; Kedzierski andYanagisawa, 2001). Synthe-
sized as pre-pro-endothelin, these precursor proteins are cleaved
by ET-converting enzymes (ECE) forming big-endothelin, which
upon further processing yields 21 amino acids ET peptides that
activate cardiovascular cells via GPCRs subtypes, ETAR and ETBR
(Dhaun et al., 2007).
Apart from its powerful vasoconstrictor effects, the pleiotropic
ET-1 induces plasma exudation (Filep et al., 1993; Sampaio et al.,
2000). Hemodynamic changes such as those provoked by shear
stress are sensed by the endothelium, which responds by activat-
ing eNOS and early up-regulating ET-1 mRNA. Once released,
NO and ET-1 modulate tissue homeostasis extravascularly thro-
ugh the activation of other cell types, such as mast cells (Maurer
et al., 2004).
Recently,Andrade et al. (2012) investigated the functional inter-
play between the kinin and ETs pathways at the early stages of
infectionbyDm28cTCTs. Remarkably, the applicationof subtype-
speciﬁc antagonists of ETAR or ETBR, or the BK2R antagonist
(HOE-140) on the HCP prior to TCTs markedly reduced (∼70%)
leukocyte accumulation in microvascular beds. In addition, these
endothelin receptor (ETR) antagonists blunted plasma leakage in
the hamster cheek pouch and blocked the inﬂammatory edema
in T. cruzi-infected mice. Collectively, these results indicated that
ETRs (both subtypes) and BKRs,may propagate the inﬂammatory
wave intiated via TLR2/CXCR2 through the proteolytic activation
of the KKS.
MAST CELLS MAY COUPLE TLR2 TO ETRs/BKRs-DRIVEN
PATHWAYS OF INFLAMMATION
Levick et al. (2010) have recently drawn attention to the impor-
tance of cardiac mast cells in adverse myocardial remodeling.
Given the precedent that mast cells sense Mycobacterium tuber-
culosis via TLR2 (Carlos et al., 2009), Andrade et al. (2012) have
speculated that Dm28c TCTs may directly activate ET-positive
mast cells (Ehrenreich et al., 1992) via TLR2, perhaps upregulat-
ing the extravascular levels of ETs in the chagasic myocardium.
Although plausible, the pathogenic role of TLR2-positive car-
diac mast cells in CCM was not object of systematic investiga-
tions so far. Focusing on other aspects of chagasic pathology,
Meuser-Batista et al. (2011) have recently reported that cardiac
mast cells die by apoptosis in CBA-infected mice, presumably
reﬂecting reduced production of stem cell factor in chagasic
heart.
Studies in other disease settings have shown that ET-1 acti-
vates ETAR-positive mast cells in autocrine manner, inducing
secretion of potent vasoactive mediators, such as histamine,
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leukotriene C4 (Yamamura et al., 1994), and TNF-α (Coulombe
et al., 2002). Of further interest, there is evidence that ET-1
induces metalloproteinase-driven ventricular remodeling in mod-
els of chronic heart pressure/volume overload (Murray et al., 2004;
Janicki et al., 2006) and modulate cardiac contractility through
the induction of mast cell degranulation via ETAR (Eszlári et al.,
2008). Although the role of the ET-1/mast cell axis was not
directly investigated in CCM, there is evidence that plasma levels
of ET-1 are elevated both in chagasic patients and experimentally
infectedmice (Petkova et al., 2000; Salomone et al., 2001), presum-
ably reﬂecting increased shear stress or other infection-associated
hemodynamic alterations in these individuals. Furthermore, as
highlighted earlier in this text, the expression of ETs is up-
regulated in parasitized cardiomyocytes (Tanowitz et al., 2005).
Thus, irrespective of the source of ET-1, it is conceivable that
the sudden rise in the extravascular levels of this potent pro-
oxidative mediator may lead to the activation of perivascular
ETAR-positive mast cells in the chagasic heart. According to this
hypothetical scenario, mast cell degranulation via ETAR may
release histamine, chemokines, along with a myriad of vasoac-
tive mediators, in the parasite-ladden cardiac tissues (Figure 2B).
More recently, Nascimento et al. (2012) have started to investi-
gate this hypothesis by interfering with mast cell function in HCP
topically exposed to Dm28 TCTs. Using mast cell stabilizers, we
found that plasma leakage (BK2R-driven) was indeed inhibited,
thus suggesting that mast cell degranulation is required for overt
activation of the KKS in peripheral sites of chagasic infection
(Figure 2B).
Thus far, the mechanisms by which mast cells may propagate
the KKS cascade in peripheral sites of T. cruzi infection remain
unknown. In an interesting precedent coming from mouse mod-
els of allergic inﬂammation, Oschatz et al. (2011) have recently
proposed that heparin (a mast cell storage product) acts as a
typical endogenous “contact” activator, i.e., it activates PKa in
FXIIa/HK-dependent manner, thereby releasing BK. Alternatively,
parasite-induced activation of cardiac mast cells may activate the
KKS through the formation of DNA-containing extracellular traps
(von Köckritz-Blickwede et al., 2008). Further studies may deter-
mine if the ET/mast cell/KKS pathway plays an important role in
the pathogenesis of CCM.
BK2R IS ESSENTIAL FOR DEVELOPMENT OF ACQUIRED
IMMUNE RESISTANCE TO CHAGASIC INFECTION
Comprising a heterogeneous population of professional APCs,
DCs are widely but sparsely distributed in peripheral tissues
and lymphoid organs (Shortman and Naik, 2007). Strategically
positioned in T cell-rich areas of secondary lymphoid tissues, the
resident DCs are specialized in antigen-presentation to CD4+ and
CD8+ T cells. In steady-state conditions, immature DCs present
MHC-restricted antigen peptides to virgin T cells in the absence
of co-stimulatory molecules, hence contributing to the mainte-
nance of peripheral tolerance (Sela et al., 2011). However, during
infection, the immature DCs sense “danger” motifs expressed by
pathogens through distinct families of PRRs, such as TLRs or
intracellular NOD2-like receptors (NLR; Akira, 2009). In addi-
tion, conventional DCs may sense the threat to tissue integrity
via receptors for endogenous proinﬂammatory mediators, such
as ATP, uric acid (Sansonetti, 2006), and BK (Aliberti et al.,
2003; Monteiro et al., 2007). Stabilized by cognate interactions
with co-stimulatory molecules (CD80/86, CD40, and MHC), the
prolonged encounters between antigen-bearing DCs and naïve
T cells are essential for TCR activation. During the course of
DC/T cell interaction, the “mature” APCs deliver TH polarizing
cytokines, such as IL-12p-70, which is critically required for TH1
development.
Efforts to characterize the activation pathways controlling
DC maturation in the context of T. cruzi infection have ini-
tially converged to nucleic acid-sensing TLRs (3, 7, and 9).
In a key study, Caetano et al. (2011) showed that transgenic
mice strains which lack functional UNC93B1 as well as func-
tional endosomal TLRs (TLR3, 7, and 9), were as susceptible
to T. cruzi infection as mice deﬁcient in TLR3/7/9 (Caetano
et al., 2011). In the same study, it was documented that T.
cruzi-infected macrophages and DCs from 3 day mice displayed
low IL-12p40 and INF-γ responses. Based on these results, it
was inferred that recognition of intracellular parasites require
UNC93B1-driven translocation of the nuclei acid-sensing TLRs
from the endoplasmic reticulum to the endolysosomes (Caetano
et al., 2011). In spite of this conceptual advance, other studies
suggest that DCs might sense T. cruzi through TLR-independent
pathways. For example, Kayama et al. (2009) showed that T.
cruzi induces maturation (up-regulation of MHC class II, CD40,
and CD86) of MyD88−/−TRIF−/− mice bone-marrow-derived
DCs as efﬁciently as wild-type bone-marrow-derived DCs. Using
fetal liver DCs as target cells, these authors linked the T. cruzi-
induced responses (IFN-γ production and DC maturation) to
the activation of the NFATc1 pathway. These results implied that
innate immunity is not exclusively controlled by nucleic acid-
sensing TLRs.
Several years ago, we reported that that BK, acting as a typical
endogenous danger signal (i.e., TH1-directed endogenous adju-
vant) induced DC maturation (IL-12 and up-regulated expression
of co-stimulatory molecules) via BK2R (Aliberti et al., 2003).
In a key ﬁnding, we subsequently reported that BK2R-deﬁcient
mice succumbed to acute challenge by Dm28c TCTs (i.p. route).
Analysis of the immune dysfunctions underlying the susceptible
phenotype of BK2R−/− mice at early stages of infection showed
a modest, but signiﬁcant drop in the frequency of intracardiac
type-1 effector T cells. Intriguingly, however, as the acute infection
progressed in BK2R−/− mice, the immune deﬁciency was inten-
siﬁed and generalized, involving both the extra-lymphoid and
lymphoid compartment. Of note, the decayed TH1 response of
BK2R−/− was accompanied by a corresponding rise in IL-17-
producing T cells (TH17). The premise that the deﬁcient adaptive
response of BK2R−/− mice was a secondary manifestation result-
ing from impaired BK2R−/− DC maturation was conﬁrmed by
systemically injecting wild-type BK2R+/+ DCs into the suscep-
tible BK2R−/− mice, prior to pathogen injection. Remarkably,
this DC transfer maneuver rendered the recipient BK2R−/− mice
resistant to acute T. cruzi challenge, and restored their capabil-
ity to generate protective IFN-γ-producing CD4+ CD44+ and
CD8+ CD44+ effector T cells, while conversely suppressing
the potentially detrimental TH17 (CD4+ subset) anti-parasite
responses.
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In the same study, Monteiro et al. (2007) further demonstrated
that Dm28c TCTs potently activated BK2R+/+ CD11c+ DCs
(splenic origin) but not BK2R−/− DCs, using IL-12 secretion and
expression of co-stimulatory molecules (CD86, CD80, CD40) as
read-out for DC maturation in vitro. Of further interest, K11777-
treated trypomastigote failed to robustly activate wild-type DCs,
thus linking generation of the BK2R agonist (DC maturation sig-
nal) to the proteolytic activity of cruzipain. Noteworthy, Dm28c
TCTs also induced the maturation of (splenic) TLR2−/− CD11c+
DCs and TLR4 mutant (C3H/HeJ) via BK2R, thus precluding
cooperative signaling between this GPCR and either one of these
surface PRRs. Admittedly, these results do not exclude the possi-
bility that enhanced parasite uptake via the BK2R pathway might
have indirectly facilitated nucleic acid-sensing by TLRs residing
in endolysosomes of immature splenic DCs. In any case, whether
acting as a classical sensor receptor, and/or as a upstream pathway
that potentiates TLR-signaling by parasite DNA or ssRNA, these
results are in line with the concept that kinin “danger” signals pro-
teolytically released by TCTs convert splenic BK2R+/+ DCs into
inducers of type 1 immunity (Monteiro et al., 2007). Considering
that the splenic parenchyma is continuously exposed to plasma
proteins, it is conceivable that ﬂagellated trypomastigotes navigat-
ing through the splenic stromamight be facedwith abundant levels
of blood-borne kininogens, most likely associated to ECM or cell-
surface sulfated proteoglycans. Accordingly, we may predict that
antigen-bearing CD11c+ DCs (bearing T. cruzi antigens) residing
in the spleen (and/or liver) stroma are converted into TH1 induc-
ers following exposure to high-levels of kinin “danger” signals. To
this date, studies of BK2R function in human DCs were limited
to lineages derived from monocytes exposed to granulocyte-
macrophage colony-stimulating factor (GM-CSF)/IL-4. Using this
experimental model, Bertram et al. (2007) reported that BK2R sig-
naling promotes DCmigration although BK, per se, did not induce
the maturation of human DCs. However, in subsequent stud-
ies Kaman et al. (2009) suggested that BK2R signaling potentiates
the maturation of DCs previously “primed” via TLR4. In view
of the marked phenotypic heterogeneity of DCs (Shortman and
Naik, 2007), studies with a more representative range of human
DCs are required to determine whether BK2R is a key sensor of
T. cruzi.
In conclusion, the analysis of BK2R function in differentmodels
of acute T. cruzi infection strongly suggests that activation of the
kinin system fuels anti-parasite immunity. In the next section we
will review evidences indicating that generation of kinins in sites
of infectionmay also beneﬁtT. cruzi, hence translating intomutual
beneﬁts to the host–parasite equilibrium.
TCTs RELY ON CRUZIPAIN ACTIVITY TO INVADE
CARDIOVASCULAR CELLS VIA THE BK2R PATHWAY
As mentioned earlier, studies of T. cruzi interaction with mouse
cardiomyocytes showed that membrane-permeable irreversible
inhibitors of cruzipain impaired trypomastigote invasion and
halted intracellular growth of amastigotes (Meirelles et al., 1992).
While the studies on cruzipain-mediated pathways of invasion
were in progress, Tardieux et al. (1992) reported that T. cruzi
invades non-phagocytic cells through the induction of calcium-
regulated pathway of lysosomal exocytosis. Subsequent studies
revealed that the oligopeptidase B-mediated processing of a
polypeptide precursor accumulating in theT. cruzi cytoplasm gen-
erated the calcium-inducing signal (Caler et al., 1998; Morty et al.,
1999) that propelled parasite internalization. In a parallel devel-
opment, Leite et al. (1998) reported evidences that GPCRs were
the signal transducers of the [Ca2+]i-inducing signals generated
by the oligopeptidase B-dependent peptide. Consistent with their
working hypothesis, parasites genetically deﬁcient in oligopepti-
dase B showed impaired infectivity, suggesting that proteolytic
generation of the cytoplasmic Ca2+-inducing signal was indeed
required for the development of infective phenotype. In another
interesting study, Santana et al. (1997) described the biochemical
properties of Tc80, a serine protease displaying collagenase activ-
ity. Subsequently characterized as a prolyl oligopeptidase, Tc80
localizes in a vesicular compartment close to the ﬂagellar pocket
of trypomastigotes. Synthetic inhibitors of Tc80 potently inhib-
ited T. cruzi (Y strain) invasion of non-phagocytic cells without
interfering with the [Ca2+]i-inducing activity of parasite extracts
(Grellier et al., 2001).
Further exploring the role of cruzipain as a virulent factor,
Scharfstein et al. (2000) reported that activation of BK2R poten-
tiated parasite uptake by non-phagocytic cells. Whether using
CHO transfected cells, human umbilical vein endothelial cells
(HUVECs), primary cultures of mouse (neonatal) cardiomyocytes
(Todorov et al., 2003), or primary culture of human smooth mus-
cle cells (HSMCs;Andrade et al., 2012), these studies indicated that
the parasites relied on cruzipain activity to generate a [Ca2+]i-
inducing signal (BK2R agonist) from HK displayed on host cell
surfaces. Although the genetic ablation of the multicopy cruzipain
genes remained a technical obstacle, experiments performed with
membrane-permeable irreversible inhibitors of cruzipain and par-
asites overexpressing the cruzipain gene strongly suggested that
the trypomastigotes critically depended on the enzymatic activ-
ity of cruzipain to stimulate parasite uptake by BK2R-positive
target cells (Scharfstein et al., 2000). The authors hypothesized
that upon trypomastigote attachment (posterior end) to host cell
surfaces, the enzymatically active forms of cruzipain – local-
ized in the ﬂagellar pocket (Murta et al., 1990; Souto-Padrón
et al., 1990) – rapidly diffuse into the secluded spaces formed
by the juxtaposed host/parasite membranes (Scharfstein et al.,
2000). Once conﬁned to “synapses” (Tyler et al., 2005; But-
ler and Tyler, 2012), the active protease should be protected
from targeting by natural inhibitors, such as cystatins, soluble
forms of kininogens (Stoka et al., 1998), and α2-macroglobulin
(Araújo-Jorge et al., 1994; Morrot et al., 1997) present in intersti-
tial ﬂuids. Considering that BK2R is sequestered to membrane
rafts/caveolae (de Weerd and Leeb-Lundberg, 1997; Haasemann
et al., 1998), we hypothesized that surface-bound HK (cruzipain
substrate) may translocate in the plasma membrane before being
delivered to the site of synapse (Figure 3), thus ensuring efﬁ-
cient kinin release/BK2R-mediated signal transduction (Scharf-
stein et al., 2000; Santos et al., 2006; Scharfstein andAndrade, 2011;
Andrade et al., 2012).
While analyzing the outcome of infection in cultures of
HUVECs (resting state), we found that BK2R did not promote
parasite uptake in the absence of ACE inhibitors. This was
not unexpected, because expression of ACE, a transmembrane
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FIGURE 3 | Space filling model of GPCR-mediated invasion of
cardiovascular cells. Based on the uniﬁed model ofT. cruzi invasion
proposed by Fernandes and Andrews (2012), the scheme illustrates how
GPCRs (including BKRs/ETRs) originally conﬁned to lipid rafts or caveolae
(left side of panel) might be incorporated into the molecular platforms that
coalesce around ceramide-enriched vesicles generated by the housekeeping
mechanisms of plasma membrane repair from cellular wounds. According to
Fernandes and Andrews, extracellular calcium inﬂux resulting from cell
wounds (center of panel) trigger Ca2+-regulated lysosomal exocytosis,
which in turn leads to the secretion of acid sphingomyelinase (ASM).
Acting pericellularly, ASM generates ceramide-enriched endocytic vesicles.
Next, BKRs, ETRs, along with several other GPCRs partners and several
accessory signaling molecules translocate from lipid rafts/caveolae into
the ceramide-platforms. In the resting state, signal transduction via
BK2R/ETAR/ETBR (cross-talk) may likely depend on formation of homo or
hetero-oligomers in multimolecular platforms coalescing in ceramide-
enriched vesicles. During inﬂammation, the repertoire of GPCRs in the
ceramide-rich endocytic vesicles is modiﬁed by the incorporation of
inducible molecules, such as BK1R and CPM. ET-1 (host cell origin/
autocrine route) and des-Arg-kinins (released from surface bound HK by
cruzipain, then subsequently metabolized by CPM) bind to their respective
GPCRs (ETAR/ETBR and BK1Rs). Feedback cycles might enhance the
efﬁciency of the housekeeping plasma-membrane repair mechanisms via
BKR/ETR-driven (i) induction of the canonical pathway of Ca2+-regulated
lysosomal exocytosis and/or (ii) induction of the calcium-dependent
lysosomal fusion with the nascent parasitophorous vacuole (Andrade and
Andrews, 2004) and/or PIK3-dependent retention signals (Woolsey and
Burleigh, 2004).
metallopeptidase that potently degrades intact kinins, is strongly
upregulated by endothelial cells. As predicted, BK2R-dependent
parasite uptake by HUVECs is potentiated by ACE inhibitors
(Scharfstein et al., 2000; Todorov et al., 2003; Andrade et al., 2012).
Noteworthy, ACE inhibitors were not essential for BK2R-
driven parasite invasion of cardiomyocytes or smooth muscle
cells (Todorov et al., 2003; Andrade et al., 2012). Although the
levels of ACE were not measured, it is likely that these muscle
cells express lower levels of ACE as compared to HUVECs. Along
similar lines, TCTs induced IL-12 responses on splenic CD11c+
DCs via BK2R irrespective of presence/absence of ACE inhibitors
(Monteiro et al., 2007). In summary, the outcome of Dm28c TCT
interactionwith cells that constitutively express BK2R is controlled
by ACE in cell-speciﬁc manner.
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THE INDUCIBLE BK1R: A UBIQUITOUS GATEWAY FOR T. cruzi
INVASION OF INFLAMED TISSUES?
A major challenge in Chagas disease research is to predict the
clinical outcome of the chronic cardiomyopathy. About 30% of
these patients develop a progressive form of cardiomyopathy char-
acterized by the presence of diffused inﬂammation/ﬁbrosis. As
mentioned in the introduction, pathologists noticed the pres-
ence of microvascular abnormalities and altered ECM patterns
in the heart of CCM patients (Higuchi et al., 1999). To our
knowledge, BK1R expression was not systematically investigated
in heart autopsy studies of chagasic patients despite the indica-
tions that dysregulated BK1R function might be detrimental to the
heart in other disease models. For example, in animal models of
STZ-induced diabetic cardiomyopathy (Westermann et al., 2009),
BK1R-deﬁcient mice showed attenuated cardiomyopathy as com-
pared to wild-type mice, as evidenced by the decrease of cardiac
inﬂammation, ﬁbrosis, oxidative stress, and signiﬁcant improve-
ment of left ventricular function. Pertinent to studies linking heart
remodeling to the ET up-regulation by parasitized cardiomyocytes
(Tanowitz et al., 2005), there is indication that oxidative stress
induced by ET-1 (ETAR-driven) and angiotensin I (AT1-driven)
up-regulates BK1R, leading to activation of PI3K and MAPK
in smooth muscle (Morand-Contant et al., 2010). Although not
directly examined, it is conceivable that NF-κB-induction by
proinﬂammatory cytokines secreted by antigen-speciﬁc intracar-
diac CD8+ T cells (Padilla et al., 2009; Silverio et al., 2012) might
also up-regulate BK1R in the chagasic heart.
Todorov et al. (2003) were the ﬁrst to demonstrate that
Dm28 TCTs evoke interstitial edema via the sequential activa-
tion of BK2R/BK1R. In the same study, they highlighted the
dichotomic nature of kinin signaling pathways: the parasites were
able to invade activated target cells via the BK1R/CPM pathway
(Figure 1B). Differently from results observed in resting HUVECs
(which critically depend onACE blockade to efﬁciently internalize
TCTs via BK2R), the trypomastigotes invade lipopolysaccharide
(LPS)-treatedHUVECs through interdependent signaling (“cross-
talk”) between BK1R andBK2R (Todorov et al., 2003). Notably, the
“cross-talk”betweenBK2R andBK1Rwas also observed in invasion
assays performed with primary mouse cardiomyocytes (Todorov
et al., 2003), which are cell types that spontaneously express BK1R
in culture systems.
Although studies with non-speciﬁc kininase I inhibitors
have tentatively linked BK1R-dependent parasite uptake to the
processing activity of these carboxypeptidases, the role of
the transmembrane carboxypeptidase CPM was not directly
addressed in the above studies. As mentioned in the introduction,
BK2R agonists (BK/LBK) are converted into the BK1R agonists
(i.e., [des-Arg]-BK/LBK) either by surface CPM or by a soluble
(plasma-borne) CPM (Figure 1A and Figure 2B). Since the inter-
action medium used in our invasion assays was free of serum,
it seemed unlikely that CPN was the processing enzyme criti-
cally involved in BK1R-driven parasite invasion of LPS-HUVECs
or cardiomyocytes. Instead, we inferred that CPM is likely the
enzyme generating the BK1R agonist that propels parasite inva-
sion in our in vitro assays. Interestingly, Sangsree et al. (2003)
studied the functional interplay between CPM and BK1R in great
details in human lung microvascular cells activated by IL-1β
and IFN-γ. First, they showed that BK1R signaling is responsi-
ble for the sustained NO response induced by intact BK (BK2R
agonist), implying that CPM converted the intact BK into [des-
Arg]-kinins. Using cells transfected with genes conding for CPM
and BK1R, the authors disrupted lipid rafts with methyl-beta-
cyclodextrin (MβCD). As predicted, this maneuver reduced the
BK1R-dependent increase in [Ca2+]i in response to stimulation
with intact BK2R agonists, whereas addition of cholesterol res-
cued this BK1R-driven response. After showing that CPM and
BK1R co-localized in lipid raft/caveolin-enriched membrane frac-
tions (Zhang et al., 2008), they found that CPM/BK1R physically
interact on the cell membrane, based on co-immunoprecipitation,
cross-linking, and ﬂuorescence resonance energy transfer analysis.
In an elegant experiment using a novel fusion protein containing
CPM at the N-terminus of the BK1R, Zhang et al. (2008) showed
that these transfected cells were [Ca2+]i responsive upon stimu-
lation with intact kinins, but (as predicted) this response was no
longer impaired by MβCD or by CPM antibody.
As already mentioned, in invasion assays performed with LPS-
HUVECs or cardiomyocytes, we found that ACE inhibitors were
not required to promote parasite uptake via BK1R, as opposed
to the ACE inhibitor-dependent phenotype displayed by resting
HUVECs (Todorov et al., 2003; Andrade et al., 2012). This implies
that CPM-dependent generation of the BK1R is prioritized over
the ACE-dependent pathway of BK/LBK degradation, hence con-
sistentwith the ﬁndings reported byZhang et al. (2008). Since both
CPM/BK1RandBK1R/BK2Rare sequestered into lipid rafts and/or
caveolae, it is conceivable that these GPCRs segregate together
withHK (bound to heparan sulfate proteoglycans) into specialized
plasma membrane microdomains (Figure 3). Of further interest,
although BK2R and BK1R signal cells through fairly similar intra-
cellular pathways, the regulation of inducible BK1R differs from
BK2R in that the former is desensitized upon agonist binding only
to a limited degree (Enquist et al., 2007).
BKRs AND ETRs AS GATEWAYS FOR INVASION OF
CARDIOVASCULAR CELLS: FUNCTIONAL LINK WITH THE
SPHINGOMYELINASE-DEPENDENT PLASMA MEMBRANE
PATHWAY?
In a previous section, we reviewed results of studies showing that
Dm28c TCTs induce inﬂammatory edema through mechanisms
involving cooperation between BKRs and ETRs (Andrade et al.,
2012). To evaluate whether the parasites could exploit the ET
pathway for invasion purposes, Andrade et al. (2012) studied the
interaction of Dm28cTCTswith three types of host cells: HUVECs
(which only express ETBR), primary cultures of HSMCs (which
express ETAR and ETBR), and mouse neonatal cardiomyocytes
(expressing both subtypes of ETRs). Usingmultiple pharmacolog-
ical tools (subtype-speciﬁc ETR antagonists; neutralizing antibod-
ies for each GPCR) and, in addition, interference RNA, Andrade
et al. (2012) demonstrated that TCTs invade“resting”HUVECs via
ETBR,while invasionof themuscle cells involved activationof both
subtypes of ETRs. Notably, the combined treatment of the mus-
cle cell cultures with ETAR and ETBR subtype-speciﬁc antagonists
failed to decrease parasite infectivity of HSMC or cardiomyocytes
over values induced by the individual drugs, thus recapitulating
the “cross-talk” observed between BK2R/BK1R in cardiomyocytes
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or LPS-HUVECs (Todorov et al., 2003). Importantly, studies
with CHO-ETAR or CHO-ETBR-transfected cells demonstrated
that parasite invasion was efﬁciently blocked in subtype receptor
speciﬁc manner, implying that formation of ETAR/ETBR het-
erodimers, “per se,” is not an absolute requirement for parasite
entry. SinceG-protein-coupledB2R andETR compartmentalize in
lipid rafts/caveolae (de Weerd and Leeb-Lundberg, 1997; Bremnes
et al., 2000; Okamoto et al., 2000; Harada et al., 2002; Ostrom,
2002), we reasoned that in transfected mammalian cells the den-
sity levels of any particular GPCR (in lipid rafts/caveolae)might be
well above those found in target host cell types that naturally over-
express these receptors (Andrade et al., 2012). If true, in natural
muscle cells, the reducedproportion of any given subtype of GPCR
may be compensated by cooperative interactions involving phys-
ical association with alternative GPCR “partners.” Assuming that
ligand generation is not a limiting factor, this“space-ﬁlling model”
predicts thatGPCRs thatmight be present at higher density in such
microdomains should have a better chance to coordinate signaling
responses upon ligand binding, as seems to be the case for BK2R,
ETAR, and ETBR (Andrade et al., 2012; Figure 3).
Although we did not prove that BK2R, ETAR, and ETBR form
homo or hetero-oligomers of higher order in host cell attach-
ment sites, our pharmacological studies support this possibility.
Whether using subtype-speciﬁc GPCR antagonists, neutralizing
antibodies, or iRNA interference (ETAR), our results showed
that parasite invasion was inhibited roughly to the same extent.
Furthermore, we did not observe additive effects by combining
receptor subtype antagonists or iRNA approaches. These results
suggested that pharmacological blockade of one GPCR partner is
sufﬁcient to dismantle the signaling function of entire unit, con-
sequently reducing parasite internalization in 40–60% (Andrade
et al., 2012).
Several years ago, it was demonstrated that cholesterol-
depleting drugs reduce host cell susceptibility to T. cruzi
infection (Fernandes et al., 2007). In a subsequent study, we
explored the possibility that BKRs and ETRs compartmental-
ize in lipid rafts/caveolae, by treating HSMCs with MβCD
(Andrade et al., 2012). As predicted, the cholesterol-depleting
drug drastically reduced parasite (Dm28c) entry in HSMCs
whereas addition of exogenous cholesterol to MβCD-HSMCs
restored ETAR/ETBR/BK2R-dependent pathways of T. cruzi inva-
sion. Although the physical association of these GPCRs was not
demonstrated at the molecular level, these results suggest that the
cross-talk between ETRs and BK2R may critically depend on the
integrity of lipid rafts/caveolae (Figure 3). Interestingly, confo-
cal microscopy studies performed with antibodies to anti-ETAR
or anti-ETBR showed that parasite–cell interaction sites contained
increased clusters of theseGPCRs. These results are consistentwith
the concept that ET-1 and“kinins”activate their cognate GPCRs in
lipid rafts/caveolae, perhaps translocated to synaptic sites (Scharf-
stein et al., 2000). As explained below, it is also possible that ET-1,
ET precursors andHK (bound to heparan sulfate) exert their func-
tional roles as agonists and/or precursors of GPCR ligands after
their internalization in ceramide-enriched vesicles (Figure 3).
In a breakthrough, Fernandes et al. (2011) and Fernandes
and Andrews (2012) elaborated a uniﬁed mechanistic concept
for parasite invasion of non-phagocytic host cells which nicely
embraced two seemingly distinct internalization routes (Andrade
and Andrews, 2004; Woolsey and Burleigh, 2004), the ﬁrst one
driven by calcium-regulated lysosomal exocytosis, leading to
plasma membrane fusion and a lysosomal-independent pathway
involving parasite entry though nascent parasitophorous vacuoles.
In this uniﬁed mechanism of infection, trypomastigotes invade
host cells by subverting a housekeeping mechanism of repair from
cell wounds which crucially depends on acid sphingomyelinase
(ASM)-driven formation of ceramide-enriched endocytic vesicles.
Triggered by the formation of stable lesions in the host plasma
membrane, the repair response is initiated by the inﬂux of extra-
cellular calcium. This event in turn leads to calcium-regulated
lysosomal exocytosis and ASM secretion to the extracellular envi-
ronment. Further downstream, ASM cleaves the polar head group
of sphingomyelin, generating ceramide. The repair process is ter-
minated by the formation of endocytic vesicles, which then reseal
the original plasma membrane lesions as they internalize. T. cruzi
trypomastigotes are thought to inﬂict plasma membrane injuries
upon adherence of the vibrant ﬂagellum/cell body to the cell sur-
face. Invasion “per se” occurs after the formation of ceramide-rich
endocytic vesicles (Fernandes et al., 2011).
Although we have not provided direct evidence that BK2R,
BK1R, ETAR, ETBR are translocated from lipid and/or caveolar
microdomains into ceramide rafts of muscle cells (HSMC or car-
diomyocytes) or HUVECs, this possibility deserves to be explored
in light of evidence that ceramide-enrichedmicrodomains sponta-
neously fuse to generate large macrodomains containing receptor
clusters in multimolecular platforms (Jin et al., 2008). Using
endothelial cells derived from coronary arteries, these authors
reported that Fas-ligand driven activation of death receptor medi-
ates the formation of redox signaling platforms in lipid rafts
via ceramide production by ASM-driven hydrolysis of sphin-
gomyelin. They also showed that formation of ceramide-enriched
signaling platforms was canceled in endothelial cells treated with
inhibitors of lysosomal function. In other words, the require-
ments for the formation of multimolecular signaling platforms
in ceramide rafts of endothelial cells seem to recapitulate the
requirements for parasite invasion via the house-keeping mech-
anisms of repair from cell wounds described by Fernandes and
Andrews (2012). According our “space-ﬁlling model” (Figure 3),
the signal transduction responses coordinated by these various
GPCRs (e.g,., BK2R/ETAR/ETBR) may either occur (i) within the
synaptic sites formed soon after adhesion and/or (ii) after translo-
cation of these GPCRs into ceramide rafts, hence integrating the
above mentioned multimolecular signaling platforms. Sufﬁciently
ﬂexible, this GPCR-dependent model of parasite internalization
is compatible with linear or converging activation pathways. For
example, the linear activation mode predicts that speciﬁc GPCR
subtypes are differentially targeted to lipid rafts/caveolae or to
ceramide-enriched vesicles and/or to nascent parasitophorous
vacuoles (Figure 3). Once translocated to nascent parasitophorous
vacuoles, some of these GPCR subtypes may generate para-
site retention signals through PI3K-dependent remodelling of
the actin cytoskeleton (Woolsey and Burleigh, 2004), and/or
drive calcium-dependent lysosomal fusion to parasitophorous
vacuole (Andrade and Andrews, 2004). Multiple contacts with
the pathogen and signals transmitted by soluble agonists available
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at high levels in the edematous extracellular environment, such
as ETs, BK, DABK, may then fuel parasite uptake in vivo through
converging signaling pathways.
The possibility that these GPCRs might serve as gateways for T.
cruzi infection of heart cells is worth exploring. According to Fer-
nandes and Andrews (2012), T. cruzi propensity to invade muscle
cells is dictated by the need of muscle cells to constantly repair
sarcolemma injuries via the Ca2+-regulated pathway of lysoso-
mal exocytosis andASM-driven ceramide generation (McNeil and
Steinhardt, 2003). Future studies may clarify whether the signals
that promote parasite uptake by cardiomyocytes via interdepen-
dent signaling of (BK2R/ETAR/ETBR) may increase the efﬁciency
of the house-keeping mechanisms of muscle cell repair from
sarcolemma wounds. If conﬁrmed, the convergence of house-
keeping and GPCR-mediated signaling pathways may translate
into mutual beneﬁts to the host/parasite relationship, at least
so during the indeterminate stage of chronic infection. Inter-
estingly, the concept that BK2R signaling is protective to the
heart tissues is supported by evidences that this pathway restores
S2a-mediated sacroplasmatic Ca2+ uptake (Tschöpe et al., 2005;
Spillmann et al., 2006). As chronic pathology evolves, perhaps
the harmonious trade-off between parasite and cardiac muscle
is gradually compromised owing to the ubiquitous up-regulation
of BK1R by heart cells, including cardiomyocytes, cardiac ﬁbrob-
lasts, and inﬂammatory and/or TGF-β (regulatory/pro-ﬁbrotic)
macrophages. Flares of plasma leakage elicited by trypomastig-
otes occasionally released by from ruptured pseudocysts may
propitiate the rise of extravascular levels of [des-Arg]-BK/LBK
(BK1R agonists) and ET-1. Furthermore, the extravascular levels
of ET-1 are further elevated as result of up-regulated expression
of this the pro-oxidative mediator by parasitized cardiomyocytes
(Tanowitz et al., 2005). A vicious cycle may be installed, favoring
parasite entry in heart cells via the ETAR/ETBR/BK1R path-
way at expense of increased inﬂammation and adverse cardiac
remodeling (Figure 2B).
HOST/PARASITE BALANCE, KKS AND THE PHENOTYPIC
VARIABILITY OF T. cruzi SPECIES
The characterization of molecular determinants of pathogenic
outcome is a major goal of basic and clinical research on CCM.
Although the phenotype of theDm28cmaynot be faithfully repro-
duced by every isolate of the highly polymorphic T. cruzi species,
currently segregated into six DTUs (I–VI; Zingales et al., 2009),
we may anticipate that comparative studies with other isolates
should offer clues to understand the molecular determinant of
pathogenicity of T. cruzi. For example, it will be interesting to know
whether parasite strains belonging to particular DTUs share (or
not) the ability to induce inﬂammatory edema through the coop-
erative activation of the TLR2/CXCR2/BKR2R/BK1R/ETAR/ETBR
pathway. Although the expansion/contraction of this proteolytic
cascade must certainly depend on additional parasite and host
factors, the few players so far identiﬁed may help to investi-
gate the phenotypic variability of natural T. cruzi populations.
For example, strain-dependent variability on the expression lev-
els of tGPI or, alternatively, in the extent of obscure mechanisms
controlling shedding of lipid vesicles enriched with tGPI-linked
mucins (Trocoli-Torrecilhas et al., 2009) might inﬂuence the
trypomastigote ability to activate the KKS (Scharfstein and
Andrade, 2011)
Alternative T. cruzi ligands are also known to activate innate
sentinel cells through TLR4 (Oliveira et al., 2010), TLR9 (Baﬁca
et al., 2006), or NOD1 (Silva et al., 2010), but it is presently
unknown whether these pathways may interconnect to the KKS.
Interestingly, Petersen et al. (2005) implicated TLR2 as the main
upstream regulator of hypertrophy which T. cruzi trigger in iso-
lated cardiomyocytes. On the other hand, T. cruzi strains that
might express/shed higher levels of tGPI might somewhat blunt
this potentially adverse phenotype by favoring low-grade release
of cardioprotective kinins via cruzipain as described by Monteiro
et al., 2006. In the chronic settings, the beneﬁts of anti-apoptotic
effects attributed to puriﬁed cruzipain (Aoki Mdel et al., 2006)
and BK2R signaling (Chao et al., 2008) may be offset by the up-
regulation of BK1R, a pathway that may synergize with TLR2 and
ETAR, hence fueling inﬂammatory edema (Figure 2) and cardiac
hypertrophy in chronically infected patients.
Another mechanism that may underlie the variable phenotype
of T. cruzi strains is the variable expression proﬁles of cruzipain
isoforms (Lima et al., 2001). For example, it is well established
that cruzipain 2 (Dm28c strain) has narrow substrate speciﬁcity
as compared to the major cruzipain isoform, i.e., the parasite
kininogenase (Scharfstein, 2010). Predictably, strain-dependent
variability in the ratio of expression between these two cruzi-
pain isoforms may have impact on T. cruzi ability to invade
host cells expressing BKRs (inﬂuence on tissue tropism) as well
on its capacity to induce interstitial edema and TH1 responses
via the kinin pathway. For similar reasons, we may predict that
variations in the expression levels of chagasin, a tight-binding
endogenous inhibitor of papain-like cysteine proteases – orig-
inally described in T. cruzi (Monteiro et al., 2001), may also
inﬂuence the phenotype of T. cruzi strains. This possibility is sup-
ported by evidences (Aparício et al., 2004) indicating that TCTs
of the G strain, which are poorly infective, display increased
chagasin/cruzipain ratios as compared to Dm28c. Importantly,
the infectivity of the G strain was enhanced upon addition of
cruzipain-rich culture supernatants fromDm28TCTs. In the same
study, the authors pointed out that that vesicles shed by TCTs
might serve as cruzipain substrates, presumably generating hith-
erto uncharacterized infection-promoting signals (Scharfstein and
Lima, 2008). Hence, strain-dependent differences in the expres-
sion levels of tGPI and cruzipain isoforms may have impact on
host/parasite relationship, either because kinins inﬂuence parasite
infectivity, DC function and their ability to steer TH1-type effector
development.
CONCLUDING REMARKS
Host defense to infections depend on the mobilization of two
distinct strategies in order to minimize infection-associated
pathology: the ﬁrst, innate immunity, is mobilized at the onset
of infection with the purpose to eliminate or at least limit
the spread of pathogens to the tissues (Medzhitov, 2009). The
second strategy, involving products generated by proteolytic cas-
cades and multiple endogenous “danger” signals emanating from
injured tissues, has evolved to limit and repair the tissue dam-
age inﬂicted by the microbial pathogen. The distinction between
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the mechanism underlying these overlapping processes in chronic
parasitic infections, such as Chagas disease, is important because
they profoundly affect the evolutionary dynamics of the of host–
pathogen interactions (Rausher, 2001). Here we reviewed data
showing that infective formsofT. cruzi can evoke interstitial edema
through the activation of an inﬂammatory pathway initiated by
one PRR (TLR2) and ampliﬁed through the “sequential” activa-
tion of the following GPCRs: CXCR2/BK2R/BK1R/ETAR/ETBR
axis. Although presented as a linear cascade process for didactic
reasons, this paradigm provides a useful framework to investigate
the activation pathways that interconnect innate immunity to the
KKS, a hub-like proteolytic network that generates proinﬂamma-
tory kinin peptides while simultaneously activating three other
proteolytic cascades, i.e., complement/coagulation/ﬁbrinolytic
systems – none of which were thus far explored in the context
of CCM.
The evidence that activation of the kinin/BK2R pathway bene-
ﬁts themammalian host emerged fromour immunological studies
(Monteiro et al., 2007). The analysis of the susceptible phenotype
of BK2R-deﬁcient mice (acute chagasic infection) demonstrated
that DC sensing of the kinin “danger” signal via BK2R was essen-
tially required for optimal generation of type 1 (host protective)
effector T cells (Monteiro et al., 2007).
The dual role of the KKS in experimental Chagas disease is
so far based on evidences that Dm28c trypomastigotes exploit
BKRs/ETRs as (non-exclusive) gateways for cellular invasion of a
broad range of non-phagocytic cells, including cardiomyocytes.
We have proposed that trypomastigotes sharing the Dm28c phe-
notype might be able to transiently generate infection-promoting
peptidergic ligands for GPCRs, such as BK and ET-1, in inﬂamed
tissues through the induction of intersticial edema.
Interestingly, studies in other models of heart disease have
associated KKS/BK2R signaling with protective cardiac func-
tions, such as reducing apoptosis and chamber dilatation in the
myocardium (Chao et al., 2008) and promoting restoration of S2a-
mediated sarcoplasmatic Ca2+ uptake by cardiac cells (Tschöpe
et al., 2005). Thus, it is tempting to speculate that BK2R sig-
naling may bring about mutual beneﬁts to the host/parasite
equilibrium in the chagasic heart, perhaps during the quiescent
phase (indeterminate) of chronic disease. Interestingly, there are
a few reports describing beneﬁcial effects of continuous ACE
inhibitor treatment in animal models of Chagas disease (Leon
et al., 2003; de Paula Costa et al., 2010). Although the clini-
cal/pathological beneﬁts of ACE inhibitors in CCM might be
partially or totally ascribed to blockade in generation of pro-
ﬁbrotic angiotensin II, these results argue against an earlier propo-
sition that ACE inhibitor-dependent up-regulation of the BK2R
pathway might aggravate infection-associated pathology (Scharf-
stein et al., 2000).
In several models of sterile inﬂammation, the initial tissue
damage is sufﬁcient to initiate self-propagating biochemical and
immunological processes with the aim to protect and rescue
tissue integrity. Depending on the magnitude of the trauma,
metabolic status, and host genetics, the collateral tissue damage
associated with the activation of endogenous pathways of inﬂam-
mation in the parasitized heart (Machado et al., 2000) may be
extreme, causing irrevesible leison on cardiomyocytes. Studies
in vitro have implicated TLR2 signaling in T. cruzi-induced path-
ways leading to cardiac hypertrophy (Petersen et al., 2005). It will
be interesting to know whether the infection-associated damage
of cardiomyocytes can be attenuated upon kinin release and BK2R
signaling, perhaps reminiscent of some of the BK2R-dependent
protective responses observed in ischemia reperfusion anddiabetic
cardiomyopathy (Messadi-Laribi et al., 2008; Tschöpe and Wester-
mann, 2008).
Concerning BK1R, recent work in animal models of focal brain
injury highlights the importance of therapeutic intervention on
the KKS as a way to limit secondary damage caused by brain-
barrier leakage (Raslan et al., 2010). As shown by these authors,
pharmacological blockade of the inducible BK1R (but not BK2R)
had remarkable protective effects on traumatic brain injury. Of
interest in this context, we have previously reported that BK1R
antagonist blunts the edematogenic response elicited by Dm28c
TCTs in mice pretreated with LPS (Todorov et al., 2003).
Since chagasic patients display higher levels of ET-1 in the
bloodstream (Petkova et al., 2000; Salomone et al., 2001), it is
plausible that the edema resulting from pseudocyst rupture may
promote the diffusion of blood-borne ET-1 through perivascular
cardiac tissues. If true, these events may in turn trigger cardiac
mast cell degranulation via the ET-1/ETAR axis, thus linking the
ET pathway to the KKS (Figure 2B). Furthermore, considering
that the expression of BK1R is up-regulated by the pro-oxidative
ETs (Morand-Contant et al., 2010), and that ET-1 expression is
robustly increased in parasitized cardiomyocytes (Tanowitz et al.,
2005), it is conceivable that T. cruzi has evolved strategies to
improve its infectivity at expense of increased inﬂammation, as
recently shown in mice infected with the Y strain of T. cruzi (Paiva
et al., 2012). Following a similar line of reasoning, we may predict
that ET-1 and [des-Arg]-kinins, acting cooperatively, may pro-
pel parasite entry in cardiovascular cells through the signaling of
BK1R, a subtype of GPCR that is ubiquitously up-regulated in
inﬂamed tissues.
The sporadic formation of an intramyocardial edema in the
proximity of an inﬂammatory lesion generated by pseudocyst rup-
ture may alter tissue homeostasis, consequently modifying the
dynamics of host/parasite interaction in this microenvironment.
For example, the trypomastigotes navigating through intercellu-
lar cardiac spaces might be targeted by high-titered complement
ﬁxing/lytic antibodies (Krettli et al., 1982; Almeida et al., 1994)
and/or by antibodies that inhibit host cell invasion (Schenkman
et al., 1994; Tonelli et al., 2011). Induction of interstitial edema via
activation of KKS might favor the rapid diffusion of these host
protective antibody speciﬁcities into peripheral sites of infection.
In addition, the inﬂammatory edema may allow the diffusion of
antibodies against the C-terminal domain of cruzipain (GP25;
Scharfstein et al., 1983). Antibody targeting of the immunodom-
inant sulfated epitopes (Duschak and Couto, 2009) displayed on
the C-terminal domain of cruzipain may either limit trypomastig-
ote ability to efﬁciently invade cardiovascular cells (Meirelles
et al., 1992; Scharfstein et al., 2000) and/or prevent anti-apoptotic
responses which cruzipain otherwise induces in cardiomyocytes
(Aoki Mdel et al., 2006).
For similar reasons, the heart conduction system might be tar-
geted by auto-antibodies that are either speciﬁc for M2 muscarinic
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receptors (Medei et al., 2007) and/or β1-adrenergic receptors
(Labovsky et al., 2007). Depending on their titers and ﬁne-
speciﬁcity, these auto-antibodies may evoke arrhythmia as a
secondary consequence of plasma leakage elicited by trypomastig-
otes. If conﬁrmed, this hypothesis may legitimate attempts to treat
chagasic patients with drugs that target the ET/mast cell/KKS axis:
by limiting leakage of auto-antibodies into the myocardium, these
drugs may also mitigate cardiac arrhythmia.
Considering the long span of chronic infection, the
myocardium of patients exhibiting deﬁcient IL-10 production by
macrophages or regulatory T cells (Costa et al., 2009) might be
particularly prone to up-regulate the BK1R pathway in response
to excessive collateral damage inﬂicted by pathogenic subsets of
T cells. In this hypothetical scenario, the inﬁltrating type 1 effec-
tor CD8+ T cells may relentless fuel the pro-ﬁbrotic pathways
coordinated by BK1R/ETR. Of further interest, recent studies of
sterile inﬂammation in transgenic mice subjected to cardiac pres-
sure overload revealed that mitochondrial DNA (i.e., simulating
symbiotic bacteria) leaks into autophagic vesicles of cardiomy-
ocytes (Oka et al., 2012). Strikingly, the authors reported that the
down-regulation of DNAse II, a lysosomal enzyme, fuels sterile
inﬂammation in TLR9-dependentmanner, provided that themice
are subjected to pressure overload (Oka et al., 2012). Although
not explored in the context of CCM, it may not be surprising if
chagasic heart debilitated by microvascular lesions, hypoxia, and
immunopathology may be hyper-responsive to TLR9 signaling
induced by T. cruzi mitochondrial DNA and/or self-DNA (from
non-infected cardiomyocytes). If conﬁrmed, itwill be intriguing to
know if BK1R and ETRs, acting cooperatively in the pro-oxidative
environment that prevails in the chagasic heart (Dhiman andGarg,
2011) may up-regulate TLR9 and/or STING, another recently
characterized sensor of self-DNA (Ahn et al., 2012). Ongoing
studies in chagasic mice treated with BK1R blockers may clar-
ify whether this therapeutic strategy may reduce parasite tissue
load as well as myocardial ﬁbrosis. Moreover, it is conceivable that
BK1R antagonistsmay reduce chronic inﬂammation by preventing
microvascular leakage and/or blocking parasite-induced recruit-
ment of pathogenic subsets of anti-parasite CD8 T effector cells
into the myocardium (Silverio et al., 2012), as reported in EAE
(Dutra et al., 2011; Göbel et al., 2011).
In summary, our studies on the KKS have provided a gen-
eral framework to investigate the intertwined proteolytic circuits
that reciprocally couple anti-parasite immunity to inﬂammation
and ﬁbrosis in experimental CCM. Although limited to a single T.
cruzi strain, Dm28c, the knowledge that emerged from 20 years
of studies on this emerging ﬁeld suggest that plasma leakage into
the myocardium may shift the dynamics of host/parasite interac-
tion in the inﬂamed heart through the activation of BKRs/ETRs.
Hopefully, some of the lessons taken from this experimental work
may help to elucidate the mechanisms underlying susceptibil-
ity to CCM, perhaps assisting efforts to improve the therapeutic
management of chagasic patients.
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